Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 1689

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1A
Chunk 1689
---
, litigation matters
                                            and our ability to obtain patent protection for our technologies;

●significant
                                            lawsuits, including patent or stockholder litigation;

●changes
                                            in the structure of healthcare payments systems;

●issuance
                                            of additional shares of our Common Stock to comply with the full ratchet antidilution rights
                                            contained in our outstanding Warrants;

●failure
                                            to raise additional funds on acceptable terms, or at all;

●changes
                                            in business or regulatory conditions, including new laws or regulations or new interpretations
                                            of existing laws or regulations applicable to our business;

●general
                                            political, economic, industry and market conditions, including rising interest rates and
                                            inflation; and

●other
                                            events or factors, many of which are beyond our control.

In addition, the stock market
in general, and the markets for special purpose acquisition company post-business combination businesses and healthcare companies in particular,
have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance
of these companies. Broad market and industry factors may negatively affect the market price of our Common Stock, regardless of our actual
operating performance. In addition, price volatility may be greater if the public float and trading volume of our Common Stock is low.
If the market price of our Common Stock falls, you may not realize any return on your investment and may lose some or all of your investment.
In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market
price of a company’s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management’s
attention and resources, which would harm our business, operating results or financial condition.

Unstable market and economic conditions
may have serious adverse consequences on our business, financial condition and stock price.

The global economy, including
credit and financial markets, has experienced extreme volatility and disruptions, including severely diminished liquidity and credit availability,
declines in consumer confidence, declines in economic growth, increases in unemployment rates, increases in inflation rates, higher interest
rates and uncertainty about economic stability. For example, the Russia-Ukraine war and the Israel-Hamas war created volatility in the
global capital markets and may have further global economic consequences, including disruptions of the global supply chain and energy
markets. The imposition of tariffs by the United States on imports from Canada, China and Mexico and retaliatory tariffs or other actions
by the governments of such countries have also created economic uncertainty and disruptions in the